Implantable Cardiac Monitor (ICM)

Implantable cardiac monitors (ICM) are small electrophysiology (EP) devices that used for long-term monitoring of a patient's heart electrical activity to detect arrhythmias. The technology can eliminate the need for a bulkly external Holter monitor that requires wire leads attached to the patient. ICMs can be inserted under the skin during and office visit and record cardiac data continuously for up to 4.5 years. 

Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.

Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.

Feature | EP Lab | March 17, 2021 | By Maninder Bedi, M.D.
A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his...
The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location.

The Optimize EP CaRM software integrates data from several EP devices a patients may use and aggregate it into one location. 

News | EP Lab | February 02, 2021
February 2, 2021 – Optimize EP, a digital health company focused on transforming cardiac care by improving the current...
With the FDA clearance of the Vital Data Sensor, Biotronik's Biomonitor IIIm features two-in-one detection, providing physicians the ability to monitor for early signs of potential life-threatening cardiac arrhythmias and body temperature increases potentially associated with fever.

With the FDA clearance of the Vital Data Sensor, Biotronik's Biomonitor IIIm features two-in-one detection, providing physicians the ability to monitor for early signs of potential life-threatening cardiac arrhythmias and body temperature increases potentially associated with fever.

News | Implantable Cardiac Monitor (ICM) | December 22, 2020
December 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared Biotronik's Vital Data Sensor, which identifies...
Videos | EP Device Monitoring Systems | December 22, 2020
Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has...
The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

The Linq II implantable cardiac monitor (ICM) system delivers improved device longevity compared to other ICMs and enhanced accuracy to correctly detect abnormal heart rhythms, simplifying the diagnosis and monitoring of patients. The new devices allows continuous cardiac monitoring for up to 4.5 years.

News | Implantable Cardiac Monitor (ICM) | July 07, 2020
July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark...
First ICM device with remote programming paired with dual-stage arrhythmia detection algorithm
News | Implantable Cardiac Monitor (ICM) | June 29, 2020
June 29, 2020 — Boston Scientific received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx ...
Videos | Wearables | January 09, 2020
The Consumer Electronic Show (CES) is the world's gathering place for consumer technologies, with more than 175,000...
Researchers File Patent for Tiny Blood Flow Sensor

Image courtesy of Flinders University

News | Implantable Cardiac Monitor (ICM) | July 09, 2019
July 9, 2019 — South Australian researchers are developing a tiny fiber-optic sensor, which has the potential to change...
Biotronik Launches Biomonitor III Injectable Cardiac Monitor in the CE Region
News | Implantable Cardiac Monitor (ICM) | July 01, 2019
July 1, 2019 – Biotronik announced the European market release of its new injectable cardiac monitor (ICM), Biomonitor...
Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor
News | Implantable Cardiac Monitor (ICM) | May 06, 2019
May 6, 2019 — Abbott announced the launch of a new, smarter heart monitor for better arrhythmia detection — positive...
Murj Launches Murj 2.0 Implantable Cardiac Device Management Software
Technology | EP Device Monitoring Systems | May 01, 2019
May 1, 2019 — Digital healthcare company Murj announced the immediate availability of the Murj 2.0 implantable cardiac...
Permanent Pacing Effective for Older Patients With Syncope and Bifascicular Block
News | Pacemakers | May 24, 2018
May 24, 2018 — Syncope with bifascicular block may be caused by intermittent complete heart block, but competing...
The Angel Medical Systems' AngelMed Guardian System is an implantable cardiac monitor intended to detect and alert patients of a potential heart attack.

 The Angel Medical Systems' AngelMed Guardian System is an implantable cardiac monitor intended to detect and alert patients of a potential heart attack. 

Technology | Implantable Cardiac Monitor (ICM) | May 09, 2018
 May 9, 2018 — The U.S. Food and Drug Administration (FDA) said it recently granted market clearance for Angel Medical...
Videos | Magnetic Resonance Imaging (MRI) | December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...
The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was in October 2017.

The Abbott/St. Jude Confirm RX implantable cardiac monitor (ICM) is the first ICM that is compatible with patients' smartphones to eliminate the need for a bedside base unit monitor to transfer data to physicians. Its FDA clearance was the No. 1 most popular article on DAIC in October.

Feature | November 03, 2017 | Dave Fornell
November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional...